Comments
Healthcare player Zydus Cadila (Cadila Healthcare Limited) on Wednesday announced that the company has received the tentative approval from the US Drug Regulator, USFDA to market its Clofarabine Injection 20mg/20ml vials.
The company's share prices gained 3 per cent to trade at Rs 345.80 on the Bombay Stock Exchange in pre-close trade.
The group now has more than 100 approvals and has so far filed over 280 ANDAs since the commencement of the filing process in financial year 2003-04, the company statement said.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.